enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Corneal cross-linking - Wikipedia

    en.wikipedia.org/wiki/Corneal_cross-linking

    Corneal cross-linking (CXL) with riboflavin (vitamin B 2) and UV-A light is a surgical treatment for corneal ectasia such as keratoconus, PMD, and post-LASIK ectasia. It is used in an attempt to make the cornea stronger. According to a 2015 Cochrane review, there is insufficient evidence to determine if it is useful in keratoconus. [2]

  3. Keratoconus - Wikipedia

    en.wikipedia.org/wiki/Keratoconus

    In 2016, however, the FDA approved cross-linking surgery as a treatment for keratoconus and recommended that a registry system should be set-up to evaluate the long-term treatment effect. [ 9 ] [ 70 ] The Save Sight Keratoconus Registry is an international database of keratoconus patients that is tracking outcomes of cross-linking in patients ...

  4. Pellucid marginal degeneration - Wikipedia

    en.wikipedia.org/wiki/Pellucid_marginal_degeneration

    Intacs implants, corneal collagen cross-linking, and corneal transplant surgery are additional options. Surgery is reserved for individuals who do not tolerate contact lenses. The term "pellucid marginal degeneration" was first coined in 1957 by the ophthalmologist Schalaeppi. [ 2 ]

  5. Corneal transplantation - Wikipedia

    en.wikipedia.org/wiki/Corneal_transplantation

    Corneal transplantation, also known as corneal grafting, is a surgical procedure where a damaged or diseased cornea is replaced by donated corneal tissue (the graft). When the entire cornea is replaced it is known as penetrating keratoplasty and when only part of the cornea is replaced it is known as lamellar keratoplasty.

  6. Approved Drug Products with Therapeutic Equivalence ...

    en.wikipedia.org/wiki/Approved_Drug_Products...

    Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act). The Hatch-Waxman Act was created to '"strike a balance between two competing policy interests:

  7. Can Weight Loss Drugs Make You Boring? Doctors Explain ...

    www.aol.com/weight-loss-drugs-boring-doctors...

    The reasoning so far is simple: Just as a GLP-1 can make eating food less enjoyable because it modulates your brain’s pleasure and reward center, doctors say that it could impact how you feel ...

  8. FACT CHECK: Can Donald Trump Actually Run For A Third ... - AOL

    www.aol.com/fact-check-donald-trump-actually...

    A post on X shows Trump ally Steve Bannon stating that President-Elect Donald Trump can actually run for a third term as President by law. Verdict: False The 22nd amendment of the U.S ...

  9. How to retire on less than $1 million and never run out of money

    www.aol.com/finance/retire-less-1-million-never...

    Bottom line. Ultimately, whether you can retire on less than $1 million will largely depend on your spending needs during retirement and your remaining life expectancy.